Home > Income Statement > BAFNA PHARMACEUTICALS

BAFNA PHARMACEUTICALS
Revenue

    Back to Income Statement
BAFNA PHARMACEUTICALS is part of below Screeners ↓
Best Quarterly Growth Small Cap Stocks
Best 1M Momentum Small Cap Stocks
COMMUNITY POLL
for BAFNA PHARMACEUTICALS
Please provide your vote to see the results

BAFNA PHARMACEUTICALS Last 5 Year Revenue History

[Standalone]

Mar2025Mar2024Mar2023Mar2022Mar2021
Net Sales ₹152 Cr₹115 Cr₹85 Cr₹71 Cr₹42 Cr

What is the latest Revenue of BAFNA PHARMACEUTICALS ?

The latest Revenue ratio of BAFNA PHARMACEUTICALS is ₹152 Cr based on Mar2025 Standalone results.
Year Revenue
Mar2025₹152 Cr
Mar2024₹115 Cr
Mar2023₹85 Cr
Mar2022₹71 Cr
Mar2021₹42 Cr

How is Revenue of BAFNA PHARMACEUTICALS Trending?

Years Revenue % Change
Mar2025 ₹152 Cr
32.18
Mar2024 ₹115 Cr
35.48
Mar2023 ₹85 Cr
19.55
Mar2022 ₹71 Cr
67.68
Mar2021 ₹42 Cr -

Compare Revenue of peers of BAFNA PHARMACEUTICALS

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
BAFNA PHARMACEUTICALS ₹544.2 Cr 21.5% 63.5% 199.6% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹447,704.0 Cr -0.5% 3.9% 12.1% Stock Analytics
DIVIS LABORATORIES ₹173,684.0 Cr -3.1% -0.1% 0.2% Stock Analytics
TORRENT PHARMACEUTICALS ₹157,093.0 Cr 3.1% 6.7% 45.5% Stock Analytics
CIPLA ₹117,699.0 Cr 1.4% 4.8% -2.5% Stock Analytics
DR REDDYS LABORATORIES ₹111,792.0 Cr 0.8% 3.9% 1.5% Stock Analytics


BAFNA PHARMACEUTICALS Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
BAFNA PHARMACEUTICALS

21.5%

63.5%

199.6%

SENSEX

1%

2.9%

-6.1%


You may also like the below Video Courses